Clinical Trial Update: Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) [Phase 3]

View source ↗

Summary

Phase 3 trial of tinzaparin (low molecular weight heparin) in non-small cell lung cancer has completed. The update does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• tinzaparin (tinzaparin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lung Cancer, Non Small Cell Lung Cancer | Phase 3 | Status: COMPLETED